Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

828
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
828

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In silico study of hyposalivation and sugar exposure on biofilm dysbiosis.

JADA foundational science·2026
Same author

Bayesian Optimization of Catalysis with In-Context Learning.

ACS central science·2026
Same author

A multi-agent system for automating scientific discovery.

Nature·2026
Same author

Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial.

Nature communications·2026
Same author

MDCrow: automating molecular dynamics workflows with large language models.

Machine learning: science and technology·2026
Same author

Nutritional pressure from serum amplifies dysbiotic features in an oral microbiome synthetic community.

The ISME journal·2026

Related Experiment Video

Updated: May 1, 2026

Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
06:13

Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens

Published on: November 23, 2010

34.3K

ELISPOT Refinement Using Spot Morphology for Assessing Host Responses to Tuberculosis.

Laura S Sibley1, Andrew D White2, Alice Marriott3

  • 1Microbiological Services, Health Protection Agency Porton, Porton Down, Salisbury, Wiltshire SP4 0JG, UK. Laura.Sibley@hpa.org.uk.

Cells
|April 9, 2014
PubMed
Summary
This summary is machine-generated.

The interferon gamma (IFNγ) ELISPOT assay, used for tuberculosis vaccine research, can be improved by analyzing spot size alongside spot forming units (SFU). This enhances its ability to measure immune responses to BCG vaccination and M.tb infection.

More Related Videos

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

14.5K
Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

13.8K

Related Experiment Videos

Last Updated: May 1, 2026

Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
06:13

Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens

Published on: November 23, 2010

34.3K
Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

14.5K
Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

13.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a significant global health challenge, necessitating the development of more effective vaccines beyond the current Mycobacterium bovis Bacille Calmette Guerin (BCG) vaccine, which exhibits variable efficacy.
  • Interferon gamma (IFNγ) is a critical cytokine in the immune response to Mycobacterium tuberculosis (M. tb) and is a key biomarker for assessing the immunogenicity of new TB vaccine candidates.

Purpose of the Study:

  • To investigate the utility of incorporating spot size analysis into the IFNγ ELISPOT assay for evaluating BCG vaccine immunogenicity and M. tb infection.
  • To determine if combining spot size with traditional spot forming units (SFU) enhances the discriminatory power of the ELISPOT assay.

Main Methods:

  • Utilized the IFNγ ELISPOT assay to capture and enumerate IFNγ-producing peripheral blood mononuclear cells (PBMCs) after specific stimulation.
  • Employed AID ELISPOT plate reader software to measure both the frequency (SFU) and size of IFNγ spots.
  • Analyzed BCG immunogenicity and M. tb infection responses by considering both SFU and spot size.

Main Results:

  • The standard SFU measurement of ELISPOT assays has limitations in differentiating immune responses, particularly in BCG-vaccinated versus unvaccinated individuals.
  • Spot size analysis, reflecting the quantity of cytokine produced per cell, provided additional discriminatory power when combined with SFU.
  • The integrated analysis of SFU and spot size offered a more comprehensive understanding of the immune response to BCG vaccination and M. tb infection.

Conclusions:

  • Incorporating spot size measurement into the IFNγ ELISPOT assay significantly enhances its ability to assess immune responses to TB vaccines and infection.
  • This enhanced ELISPOT assay provides a more nuanced evaluation of vaccine immunogenicity and the host's response to M. tb.
  • Spot size analysis represents a valuable advancement for TB research, diagnostics, and vaccine development.